208
Participants
Start Date
July 31, 1993
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
Genotonorm
0.7 IU/kg/week or 0.03 mg/kg/day, daily subcutaneous injection
Genotonorm
1.4 IU/kg/week or 0.06 mg/kg/day, daily subcutaneous injection
Genotonorm
1.4 IU/kg/week or 0.06 mg/kg/day, daily subcutaneous injection Intermittent treatment (6 months with treatment and 6 months without)
Pfizer Investigational Site, Marseille
Pfizer Investigational Site, Dijon
Pfizer Investigational Site, Besançon
Pfizer Investigational Site, Brest
Pfizer Investigational Site, Toulouse
Pfizer Investigational Site, Bordeaux
Pfizer Investigational Site, Bordeaux
Pfizer Investigational Site, Montpellier
Pfizer Investigational Site, Rennes
Pfizer Investigational Site, Tours
Pfizer Investigational Site, Grenoble
Pfizer Investigational Site, Grenoble
Pfizer Investigational Site, Saint-Priest-en-Jarez
Pfizer Investigational Site, Nantes
Pfizer Investigational Site, Angers
Pfizer Investigational Site, Reims
Pfizer Investigational Site, Vandœuvre-lès-Nancy
Pfizer Investigational Site, Lille
Pfizer Investigational Site, Lille
Pfizer Investigational Site, Clermont-Ferrand
Pfizer Investigational Site, Strasbourg
Pfizer Investigational Site, Bron
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Rouen
Pfizer Investigational Site, Amiens
Pfizer Investigational Site, Hyères
Pfizer Investigational Site, Boulogne
Pfizer Investigational Site, Nice
Pfizer Investigational Site, Tarbes
Lead Sponsor
Pfizer
INDUSTRY